|
YEATS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.48739950648292E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.45539996615685E-09 |
| Normal-vs-Stage2 |
4.49859999995805E-06 |
| Normal-vs-Stage3 |
7.92980003883059E-09 |
| Normal-vs-Stage4 |
1.61910040930024E-10 |
| Stage1-vs-Stage2 |
7.813600E-01 |
| Stage1-vs-Stage3 |
4.854200E-01 |
| Stage1-vs-Stage4 |
1.682090E-02 |
| Stage2-vs-Stage3 |
8.336000E-01 |
| Stage2-vs-Stage4 |
1.628400E-01 |
| Stage3-vs-Stage4 |
1.499970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59430024737617E-10 |
| Normal-vs-AfricanAmerican |
1.776240E-02 |
| Normal-vs-Asian |
6.9028000004856E-07 |
| Caucasian-vs-AfricanAmerican |
6.602000E-02 |
| Caucasian-vs-Asian |
7.336000E-01 |
| AfricanAmerican-vs-Asian |
7.296500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06649999942476E-08 |
| Normal-vs-Female |
1.84430026806126E-10 |
| Male-vs-Female |
9.397600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.02900000029405E-08 |
| Normal-vs-Age(41-60Yrs) |
2.72449995897261E-09 |
| Normal-vs-Age(61-80Yrs) |
5.80299996943978E-09 |
| Normal-vs-Age(81-100Yrs) |
4.558000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.934800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.377400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.339600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.724000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.222200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.166800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.342200E-01 |
| Classical-VS-Follicular |
4.051800E-01 |
| Classical-VS-Other |
8.890800E-01 |
| Classical-VS-Normal |
5.40850031427453E-10 |
| Tall-VS-Follicular |
4.431000E-01 |
| Tall-VS-Other |
8.195400E-01 |
| Tall-VS-Normal |
1.560420E-04 |
| Follicular-VS-Other |
8.809400E-01 |
| Follicular-VS-Normal |
5.21779999984595E-07 |
| Other-VS-Normal |
2.210200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.20269999409817E-09 |
| Normal-vs-N1 |
1.32110000716779E-09 |
| N0-vs-N1 |
9.726000E-02 |
|
|
